Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibilityVUORELA, Mikko; PYLKÄS, Katri; KOSMA, Veli-Matti et al.Breast cancer research and treatment. 2011, Vol 130, Num 3, pp 1003-1010, issn 0167-6806, 8 p.Article

Central European BRCA2 mutation carriers: Birth cohort status correlates with onset of breast cancerTEA, Muy-Kheng M; KROISS, Regina; MUHR, Daniela et al.Maturitas (Amsterdam). 2014, Vol 77, Num 1, pp 68-72, issn 0378-5122, 5 p.Article

A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer familiesROMERO, Atocha; PEREZ-SEGURA, Pedro; TOSAR, Alicia et al.Breast cancer research and treatment. 2011, Vol 129, Num 3, pp 939-946, issn 0167-6806, 8 p.Article

No evidence of involvement of germline BACH1 mutations in Finnish breast and ovarian cancer familiesKARPPINEN, S.-M; VUOSKU, J; HEIKKINEN, K et al.European journal of cancer (1990). 2003, Vol 39, Num 3, pp 366-371, issn 0959-8049, 6 p.Article

Comparing family members' motivations and attitudes towards genetic testing for hereditary breast and ovarian cancer: a qualitative analysisDANCYGER, Caroline; SMITH, Jonathan A; JACOBS, Chris et al.European journal of human genetics. 2010, Vol 18, Num 12, pp 1289-1295, issn 1018-4813, 7 p.Article

A gift or a yoke? Women's and men's responses to genetic risk information from BRCA1 and BRCA2 testingD'AGINCOURT-CANNING, L.Clinical genetics. 2006, Vol 70, Num 6, pp 462-472, issn 0009-9163, 11 p.Article

Women's satisfaction with genetic counseling for hereditary breast-ovarian cancer: Psychological aspectsTERCYAK, Kenneth P; DEMARCO, Tiffani A; MARS, Bryn D et al.American journal of medical genetics. 2004, Vol 131A, Num 1, pp 36-41, issn 0148-7299, 6 p.Article

Attitudes of high-risk women toward preimplantation genetic diagnosisQUINN, Gwendolyn; VADAPARAMPIL, Susan; WILSON, Crystal et al.Fertility and sterility. 2009, Vol 91, Num 6, pp 2361-2368, issn 0015-0282, 8 p.Article

Sex ratio distortion in offspring of families with BRCA1 or BRCA2 mutant alleles : an ascertainment bias phenomenon?BALMANA, Judith; DIEZ, Orland; CAMPOS, Berta et al.Breast cancer research and treatment. 2005, Vol 92, Num 3, pp 273-277, issn 0167-6806, 5 p.Article

BRCA1/2 testing in hereditary breast and ovarian cancer families: Effectiveness of problem-solving training as a counseling interventionMCLNERNEY-LEO, Aideen; BIESECKER, Barbara Bowles; HADLEY, Donald W et al.American journal of medical genetics. 2004, Vol 130A, Num 3, pp 221-227, issn 0148-7299, 7 p.Article

Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patientsCLAES, Erna; EVERS-KIEBOOMS, Gerry; BOOGAERTS, Andrea et al.American journal of medical genetics. 2003, Vol 116A, Num 1, pp 11-19, issn 0148-7299, 9 p.Article

BRCA2 germline mutations in primary cancer of the fallopian tubeCASARSA, Sara; PUGLISI, Fabio; BAUDI, Francesco et al.Oncology reports. 2004, Vol 12, Num 2, pp 313-316, issn 1021-335X, 4 p.Article

Earlier Age of Onset of BRCA Mutation-Related Cancers in Subsequent GenerationsLITTON, Jennifer K; READY, Kaylene; ARUN, Banu K et al.Cancer. 2012, Vol 118, Num 2, pp 321-325, issn 0008-543X, 5 p.Article

Prophylaktische Chirurgie bei Brust-und Eierstockkrebsrisiko. Ein Überblick über die internationale Forschungsliteratur zu Einstellungen, Inanspruchnahmeverhalten und Lebensqualität = Prophylactic surgery in women at high risk for breast and ovarian cancer. An overview of the international literature on attitudes, uptake and quality of lifeVODERMAIER, A; BAUERFEIND, I; NESTLE-KRÄMLING, C et al.Geburtshilfe und Frauenheilkunde. 2006, Vol 66, Num 11, pp 1035-1049, issn 0016-5751, 15 p.Article

High-resolution melting analysis for rapid screening of BRCA1 and BRCA2 Spanish mutationsDE JUAN, Inmaculada; ESTEBAN, Eva; PALANCA, Sarai et al.Breast cancer research and treatment. 2009, Vol 115, Num 2, pp 405-414, issn 0167-6806, 10 p.Article

Evaluation of RAD51C as cancer susceptibility gene in a large breast-ovarian cancer patient population referred for genetic testingDE LEENEER, K; VAN BOCKSTAL, M; VAN ASPEREN, C. J et al.Breast cancer research and treatment. 2012, Vol 133, Num 1, pp 393-398, issn 0167-6806, 6 p.Article

Clinical Significance of Large Rearrangements in BRCA1 and BRCA2JUDKINS, Thaddeus; ROSENTHAL, Eric; ARNELL, Christopher et al.Cancer. 2012, Vol 118, Num 21, pp 5210-5216, issn 0008-543X, 7 p.Article

Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 geneTICHA, Ivana; KLEIBL, Zdenek; STRIBRNA, Jana et al.Breast cancer research and treatment. 2010, Vol 124, Num 2, pp 337-347, issn 0167-6806, 11 p.Article